Clinical trials
Withdrawn Phase 2 Congenital Abnormalities trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eastern Cooperative Oncology Group | 1 |
| Mesoblast International Sàrl | 1 |
| Stanford University | 1 |
| University of California, San Francisco | 1 |
| University of Medicine and Dentistry of New Jersey | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Congenital Abnormalities | 6 |
| Leukemia, Myeloid, Acute | 6 |
| Leukemia, Myeloid, Accelerated Phase | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Blast Crisis | 2 |
| Burkitt Lymphoma | 2 |
| Leukemia | 2 |
| Leukemia, Erythroblastic, Acute | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Megakaryoblastic, Acute | 2 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.